Clinical Trial Update: A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports results from a Phase 1/2 pilot study evaluating Apligraf for the treatment and prevention of recurrence of excised keloids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid

Drugs mentioned

• Apligraf

Snippet

Sponsor: Organogenesis | Conditions: Keloid | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-08-19